What is it about?
Helper-dependent adenoviral vectors deleted of all viral coding sequences, are attractive vectors for gene therapy which can efficiently transduce a wide variety of cell types and promote long-term transgene expression. However, their use is limited by the host response against capsid proteins. In this report, authors show that PEGylation of helper-dependent adenoviral vectors dampen the innate immune response against capsid proteins and eliminate any remaining toxicity associated with systemic administration of the virus. Therefore, PEGylation of helper-dependent adenoviral vectors may be appropriate for their safe and efficient use in the clinic.
Featured Image
Photo by Fusion Medical Animation on Unsplash
Read the Original
This page is a summary of: PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile, Gene Therapy, January 2005, Springer Science + Business Media,
DOI: 10.1038/sj.gt.3302441.
You can read the full text:
Resources
Contributors
The following have contributed to this page